Results 181 to 190 of about 164,355 (372)

The future of RSV prevention is behind the door: immunization or antibodies? [PDF]

, 2023
Fabio Midulla
openalex   +1 more source

Factors Affecting Immune Reconstitution Post‐Allogeneic HSCT in Children: The Case for an Individualized Approach to Vaccination

European Journal of Haematology, EarlyView.
ABSTRACT Allogeneic hematopoietic stem cell transplantation (HSCT) is increasingly used to treat malignant and non‐malignant diseases. Following allogeneic HSCT, patients are particularly vulnerable to vaccine‐preventable diseases (VPD) because conditioning depletes immune cells, including memory cells.
Hélène Buvelot, Frederic Baleydier, Laure Pittet, Geraldine Blanchard‐Rohner   +3 more
wiley   +1 more source

Epidemiological Changes in Hospitalized Bronchiolitis in Children Under 2 Years of Age in Hangzhou Before and After COVID-19 Restriction Easing

Infection and Drug Resistance
Xuchen Xu,1,* Xiya Chen,1,* Jing He,1,* Lin Su,1 Xudong Tong,2 Ying Sun,1 Shumin Huang,1 Guannan Bai,1 Zhimin Chen1 1Department of Pulmonology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for
Xu X, Chen X, He J, Su L, Tong X, Sun Y, Huang S, Bai G, Chen Z   +8 more
doaj  

Green Initiatives, Financial Performance, and Institutional Investors

European Financial Management, EarlyView.
ABSTRACT Sustainability in corporate finance has gained prominence under growing societal and regulatory pressures. Green initiatives, encompassing sustainable technologies and practices, enhance environmental responsibility, financial performance, and competitiveness.
Giuseppe Galloppo, Roberto Guida, Roberto Urbani   +2 more
wiley   +1 more source

Lung organoids as a human system for Mycobacteria infection modeling and drug testing

The FEBS Journal, EarlyView.
Mycobacterial infections, including tuberculosis (TB) and infections by nontuberculous mycobacteria (NTM), are still public health issues. In 2023, TB caused 1.25 million deaths, while NTM remain a clinical challenge for patients with cystic fibrosis (CF).
Stephen Adonai Leon‐Icaza, Romain Vergé, Raoul Mazars, Laurence Berry, Céline Cougoule   +4 more
wiley   +1 more source

2777. Live-Attenuated Vaccine Against RSV Generates Robust Cellular and Humoral Immune Responses [PDF]

, 2019
Steffen Mueller, Cyril Le Nouën, Ursula J. Buchholz, Raj Kalkeri, Fusataka Koide, Peter L. Collins, J. Robert Coleman   +6 more
openalex   +1 more source

Clinical Evaluation of the GeneXpert ^® Xpert ^® Xpress SARS-CoV-2/Flu/RSV PLUS Combination Test [PDF]

, 2022
Grant Johnson, Branden S. J. Gregorchuk, Arek Zubrzycki, Kurt Kolsun, Adrienne F. A. Meyers, Paul Sandstrom, Michael G. Becker   +6 more
openalex   +1 more source

Sacubitril/Valsartan Attenuates Inflammation and Fibrosis Associated With Decreased Integrin α8 and Inhibits Hepatocarcinogenesis in a Rat Model of Metabolic Dysfunction‐Associated Steatohepatitis

Hepatology Research, EarlyView.
Sacubitril/Valsartan (Sac/Val) alleviates fibrosis and inflammation in metabolic dysfunction‐associated steatohepatitis (MASH). Its anti‐fibrotic effect is linked to the suppression of Integrin alpha 8 (Itga8), a protein crucial for hepatic stellate cell (HSC) activation and collagen production.
Hayato Kawamura, Aya Naiki‐Ito, Xiaochen Kuang, Akihiro Murakami, Masayuki Komura, Takanori Suzuki, Hiroyuki Kato, Yuko Nagayasu, Kentaro Matsuura, Kei Fujiwara, Hiromi Kataoka, Satoru Takahashi   +11 more
wiley   +1 more source

Natural‐based antioxidants in cosmeceuticals: Extraction, bioavailability and skin ageing applications

International Journal of Cosmetic Science, EarlyView.
Natural antioxidants from plants, fruits, seeds and fungi combat ageing by neutralizing free radicals, boosting collagen and protecting against UV damage. Enhanced by green extraction and smart delivery systems, they offer powerful anti‐inflammatory and antimicrobial benefits.
Hossein Omidian, Arnavaz Akhzarmehr, Charise Dallazem Bertol   +2 more
wiley   +1 more source

ARTIC RSV amplicon sequencing reveals global RSV genotype dynamics

Wellcome Open Research
Background Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections (LTRIs) in young children and adults over 65, contributing significantly to global healthcare burdens. With the recent approval of multiple pharmacological interventions for RSV, there is an increased demand for efficient, high-throughput sequencing ...
Daniel M Maloney, Goncalo Fernandes, Seema Jasim, Tom Williams, Sarah Namugenyi, Michael Carr, Jennifer R Meyer, Aryan Sharma, Louise Marshal, B Ethan Nunley, Hong Xie, Mateo Carvajal, Henry D Kunerth, Arif Tanmoy, Áine O'Toole, Amelia Weixler, Kelsey R Lanter, Gabrial Gonzalez, Jaydee Sereewit, Rommel Guevara, Matt Loose, Padraic Fanning, Denisse Benítez, Juan Carlos Fernandez, Paúl Cárdenas, Daniel Hare, Alex Greninger, Thomas Williams, Gaia Nebbia, Anthony C Fries, Patrick McClure, Pavitra Roychoudhury, Xiong Wang, Senjuti Saha, Rebecca Dewar, Kate E Templeton, Andrew Rambaut   +36 more
openaire   +1 more source